Daily Medical Update

Noninfectious pleural effusion

Sunday, August 16, 2026

🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the last 12 months.

1. Diagnostic performance and safety of image-guided pleural biopsy and medical thoracoscopy for undiagnosed exudative pleural effusion: a systematic review and network meta-analysis.

European respiratory review (2026) - Systematic review and network meta-analysis

Key Findings

  • Across 64 studies involving 8744 patients, rigid medical thoracoscopy had the highest diagnostic yield at 95.0%; cryobiopsy yielded 93.1%, and semirigid thoracoscopy and ultrasound elastography-guided biopsy each yielded 92.3%.
  • Closed pleural biopsy had the lowest yield at 75.1%, while no biopsy method showed a clearly superior overall complication profile; image-guided and rigid thoracoscopy yields were not statistically different in the network comparison.

📋 Practice Implication: For unexplained exudative effusion requiring tissue, favor rigid medical thoracoscopy when broad pleural inspection, larger samples, or possible pleurodesis is valuable; select image guidance according to lesion size and location rather than assuming a universal safety advantage.

2. The accuracy of thoracic ultrasound in differentiating transudative from exudative effusions: A meta-analysis.

Respiratory medicine (2025) - Meta-analysis

Key Findings

  • An echogenic thoracic-ultrasound pattern for exudate had pooled sensitivity of 0.71, specificity of 0.92, diagnostic odds ratio of 34.82, and area under the curve of 0.81.
  • An anechoic pattern did not reliably identify transudates, and diagnostic heterogeneity was high for both sensitivity and specificity (I² 90.9% and 91.9%, respectively).

📋 Practice Implication: Use echogenicity as a rapid clue that supports exudative classification, but retain thoracentesis and pleural-fluid analysis when the diagnosis will change management or ultrasound findings are anechoic or uncertain.

3. Ultrasonic elastography-guided pleural biopsy versus traditional thoracic ultrasound-guided pleural biopsy for the diagnosis of pleural effusion: a multicentre, randomised trial.

The European respiratory journal (2025) - Multicentre randomized controlled trial

Key Findings

  • Sensitivity for malignant pleural effusion was higher with elastography-guided biopsy than traditional ultrasound-guided biopsy (85.00% versus 63.16%; p=0.007).
  • Overall diagnostic yield was also higher (87.83% versus 76.99%; p=0.032), including in malignant effusions with pleural thickness ≤5 mm and no nodules (80.49% versus 50.00%; p=0.007), while procedure-related complications were similar (6.36% versus 8.33%; p=0.552).

📋 Practice Implication: When malignant pleural effusion is suspected—especially with a thin, non-nodular pleura—elastography guidance can improve biopsy yield without an observed increase in procedural complications.

4. Ultrasound guidance compared to anatomic landmark approach for thoracentesis: A systematic review and meta-analysis.

The American journal of emergency medicine (2025) - Systematic review and meta-analysis

Key Findings

  • Ultrasound-guided thoracentesis succeeded in 195 of 202 procedures (96.5%), compared with 189 of 215 (87.9%) using anatomic landmarks; the pooled success estimate favored ultrasound (OR 3.99, 95% CI 0.60–26.50).
  • Post-procedure pneumothorax occurred in 1 of 99 ultrasound-guided procedures versus 20 of 113 landmark procedures, and the pooled complication estimate favored ultrasound (OR 0.18, 95% CI 0.01–3.07).

📋 Practice Implication: Use real-time ultrasound for thoracentesis whenever available to improve site selection and procedural safety, while recognizing that the randomized evidence base was small and the pooled confidence intervals were imprecise.

5. Medical thoracoscopy with talc poudrage and indwelling pleural catheter insertion versus medical thoracoscopy with talc poudrage alone for patients with symptomatic malignant pleural effusion (TACTIC): a randomised, controlled phase 3 trial.

The Lancet. Respiratory medicine (2026) - Phase 3 randomized controlled trial

Key Findings

  • Median time in hospital was 1 day with talc poudrage plus an indwelling pleural catheter versus 2 days with poudrage alone (p=0.26), and median dyspnea scores did not differ (14.0 versus 19.6 mm; p=0.26).
  • By 12 weeks, additional invasive pleural procedures were required in 2 of 60 patients (3%) with the combined approach versus 19 of 56 (34%) with poudrage alone (p<0.0001); adverse-event rates were similar (74% versus 71%).

📋 Practice Implication: Consider adding an indwelling pleural catheter during thoracoscopy and poudrage when avoiding repeat pleural procedures is a priority; do not expect a significant improvement in dyspnea or initial hospital duration.

💡 Summary

Across five high-significance studies, ultrasound features offered useful but incomplete classification of transudative versus exudative effusions, while ultrasound guidance improved procedural performance and elastography increased malignant-pleural-biopsy sensitivity without more complications. In symptomatic malignant effusion, adding an indwelling pleural catheter to talc poudrage did not significantly improve hospital stay or dyspnea but markedly reduced additional invasive pleural procedures.

Generated from 57 PubMed abstracts · RCTs and Meta-analyses only

Next topic: Glomerular hematuria

Unsubscribe  ·  Subscribe